HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Min Ren Selected Research

CP-673,451

10/2021AKT1-CREB stimulation of PDGFRα expression is pivotal for PTEN deficient tumor development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Min Ren Research Topics

Disease

25Neoplasms (Cancer)
04/2022 - 04/2010
10Hypertension (High Blood Pressure)
05/2022 - 05/2010
9Hepatocellular Carcinoma (Hepatoma)
09/2022 - 04/2011
9Melanoma (Melanoma, Malignant)
01/2022 - 11/2015
4Breast Neoplasms (Breast Cancer)
01/2022 - 01/2017
4Endometrial Neoplasms (Endometrial Cancer)
01/2022 - 09/2015
4Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 08/2015
3Neoplasm Metastasis (Metastasis)
01/2021 - 04/2011
3Infections
09/2020 - 12/2010
3Proteinuria
10/2019 - 11/2015
3Seizures (Absence Seizure)
11/2016 - 01/2014
2Body Weight (Weight, Body)
01/2021 - 11/2018
2Stroke (Strokes)
01/2021 - 11/2020
2Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2020
2Stomach Neoplasms (Stomach Cancer)
01/2020 - 02/2014
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2020 - 10/2016
2Atherosclerotic Plaque (Atheroma)
01/2020 - 04/2015
2Coronary Disease (Coronary Heart Disease)
05/2019 - 03/2019
2Carcinogenesis
01/2017 - 02/2014
2Necrosis
10/2016 - 07/2008
2Ischemia
10/2016 - 04/2008
2Disease Progression
01/2016 - 08/2015
2Fatigue
01/2016 - 11/2015
2Infarction (Infarctions)
01/2016 - 04/2008
2Inflammation (Inflammations)
03/2014 - 12/2010
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2022
1Febrile Neutropenia
01/2022
1Triple Negative Breast Neoplasms
01/2022
1Neutropenia
01/2022
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022
1Squamous Intraepithelial Lesions
01/2022
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022
1Disease Resistance
12/2021
1Aortic Dissection
09/2021
1Acute Kidney Injury (Acute Renal Failure)
09/2021
1Hypothermia
09/2021
1Frailty
06/2021

Drug/Important Bio-Agent (IBA)

19lenvatinibIBA
09/2022 - 03/2015
9Proteins (Proteins, Gene)FDA Link
12/2021 - 06/2006
5Sorafenib (BAY 43-9006)FDA Link
01/2021 - 01/2018
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 07/2008
4Triglycerides (Triacylglycerol)IBA
05/2022 - 01/2021
4Glucose (Dextrose)FDA LinkGeneric
05/2022 - 11/2018
4Biomarkers (Surrogate Marker)IBA
01/2021 - 08/2015
4Tyrosine Kinase InhibitorsIBA
01/2020 - 03/2015
3Therapeutic UsesIBA
01/2022 - 07/2015
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 09/2020
3Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
10/2021 - 08/2015
3Capsules (Microcapsules)IBA
01/2021 - 05/2010
3ChloridesIBA
11/2020 - 04/2008
3CholesterolIBA
01/2020 - 04/2015
3LigandsIBA
05/2019 - 09/2018
3CytokinesIBA
05/2019 - 03/2014
2eribulinFDA Link
01/2022 - 01/2022
2ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2015
2Biological ProductsIBA
06/2021 - 11/2015
2ORALIT (ORS)IBA
01/2021 - 07/2018
2Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 05/2012
2AntigensIBA
01/2021 - 11/2014
2HDL CholesterolIBA
01/2021 - 05/2019
2Messenger RNA (mRNA)IBA
01/2021 - 07/2008
2qindanIBA
01/2021 - 05/2010
2Pharmaceutical PreparationsIBA
01/2021 - 11/2015
2MetalsIBA
10/2019 - 11/2016
2CreatinineIBA
10/2019 - 01/2019
2ApolipoproteinsIBA
05/2019 - 04/2015
2Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2018 - 08/2015
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2018 - 08/2015
2Pilocarpine (Ocusert)FDA LinkGeneric
11/2016 - 01/2014
2Angiopoietin-2IBA
01/2016 - 08/2015
2RNA (Ribonucleic Acid)IBA
09/2015 - 08/2015
1Small Interfering RNA (siRNA)IBA
04/2022
1Hormones (Hormone)IBA
01/2022
1pegfilgrastim (Neulasta)FDA Link
01/2022
1Surface-Active Agents (Surfactants)IBA
01/2022
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022
1Long Noncoding RNAIBA
01/2022
1CarcinogensIBA
01/2022
1Protein Kinases (Protein Kinase)IBA
12/2021
1MannosyltransferasesIBA
12/2021
1Transcription Factors (Transcription Factor)IBA
12/2021
1MAP Kinase Kinase 1IBA
12/2021
1Calmodulin (Calcium-Dependent Activator Protein)IBA
12/2021
1Calcium-Binding ProteinsIBA
12/2021
1CalciumIBA
12/2021
1MK 2206IBA
10/2021
1CP-673,451IBA
10/2021
11,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA
09/2021
1Thyroid HormonesIBA
06/2021
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
06/2021
1AntibodiesIBA
04/2021
1S100 Proteins (S 100 Protein)IBA
04/2021
1MART-1 AntigenIBA
04/2021

Therapy/Procedure

9Therapeutics
01/2022 - 09/2014
3Immunotherapy
01/2021 - 09/2018
2Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021 - 05/2010
2Drug Therapy (Chemotherapy)
01/2020 - 01/2016
1Radiotherapy
01/2022
1Continuous Renal Replacement Therapy
09/2021
1Activities of Daily Living (ADL)
06/2021